Targeting Enolase in Reducing Secondary Damage in Acute Spinal Cord Injury in Rats

被引:52
作者
Haque, Azizul [1 ]
Capone, Mollie [1 ,3 ]
Matzelle, Denise [2 ,3 ]
Cox, April [4 ]
Banik, Naren L. [1 ,2 ,3 ]
机构
[1] Med Univ South Carolina, Dept Microbiol & Immunol, 173 Ashley Ave,BSB 201, Charleston, SC 29425 USA
[2] Med Univ South Carolina, Dept Neurosurg, Charleston, SC 29425 USA
[3] Ralph H Johnson Vet Adm Med Ctr, Charleston, SC USA
[4] FirstString Res, Mt Pleasant, SC USA
基金
美国国家卫生研究院;
关键词
Spinal cord injury; Enolase; Glia; Cytokines and chemokines; Matrix metalloproteinases; NEURON-SPECIFIC ENOLASE; INFLAMMATORY CYTOKINE SECRETION; CALPAIN-MEDIATED APOPTOSIS; LYSOSOMAL THIOL REDUCTASE; T-CELL RECOGNITION; ALPHA-ENOLASE; BRAIN-INJURY; EXPRESSION; PROTEIN; INHIBITION;
D O I
10.1007/s11064-017-2291-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Spinal cord injury (SCI) is a complex debilitating condition leading to permanent life-long neurological deficits. The complexity of SCI suggests that a concerted multi-targeted therapeutic approach is warranted to optimally improve function. Damage to spinal cord is complicated by an increased detrimental response from secondary injury factors mediated by activated glial cells and infiltrating macrophages. While elevation of enolase especially neuron specific enolase (NSE) in glial and neuronal cells is believed to trigger inflammatory cascades in acute SCI, alteration of NSE and its subsequent effects in acute SCI remains unknown. This study measured NSE expression levels and key inflammatory mediators after acute SCI and investigated the role of ENOblock, a novel small molecule inhibitor of enolase, in a male Sprague-Dawley (SD) rat SCI model. Serum NSE levels as well as cytokines/chemokines and metabolic factors were evaluated in injured animals following treatment with vehicle alone or ENOblock using Discovery assay. Spinal cord samples were also analyzed for NSE and MMPs 2 and 9 as well as glial markers by Western blotting. The results indicated a significant decrease in serum inflammatory cytokines/chemokines and NSE, alterations of metabolic factors and expression of MMPs in spinal cord tissues after treatment with ENOblock (100 mu g/kg, twice). These results support the hypothesis that activation of glial cells and inflammation status can be modulated by regulation of NSE expression and activity. Analysis of SCI tissue samples by immunohistochemistry confirmed that ENOblock decreased gliosis which may have occurred through reduction of elevated NSE in rats. Overall, elevation of NSE is deleterious as it promotes extracellular degradation and production of inflammatory cytokines/chemokines and metabolic factors which activates glia and damages neurons. Thus, reduction of NSE by ENOblock may have potential therapeutic implications in acute SCI.
引用
收藏
页码:2777 / 2787
页数:11
相关论文
共 92 条
[1]
Neuron-specific enolase as a marker for acute ischemic stroke: A systematic review [J].
Anand, N ;
Stead, LG .
CEREBROVASCULAR DISEASES, 2005, 20 (04) :213-219
[2]
α-Enolase Expressed on the Surfaces of Monocytes and Macrophages Induces Robust Synovial Inflammation in Rheumatoid Arthritis [J].
Bae, Seyeon ;
Kim, Hyemin ;
Lee, Naeun ;
Won, Cheolhee ;
Kim, Hang-Rae ;
Hwang, Young-il ;
Song, Yeong Wook ;
Kang, Jae Seung ;
Lee, Wang Jae .
JOURNAL OF IMMUNOLOGY, 2012, 189 (01) :365-372
[3]
THE MULTIMOLECULAR CASCADE OF SPINAL-CORD INJURY - STUDIES ON PROSTANOIDS, CALCIUM, AND PROTEINASES [J].
BANIK, NL ;
HOGAN, EL ;
HSU, CY .
NEUROCHEMICAL PATHOLOGY, 1987, 7 (01) :57-77
[4]
Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury [J].
Banik, NL ;
Matzelle, DC ;
GanttWilford, G ;
Osborne, A ;
Hogan, EL .
BRAIN RESEARCH, 1997, 752 (1-2) :301-306
[5]
α-ENOLASE CAUSES PROINFLAMMATORY ACTIVATION OF PULMONARY MICROVASCULAR ENDOTHELIAL CELLS AND PRIMES NEUTROPHILS THROUGH PLASMIN ACTIVATION OF PROTEASE-ACTIVATED RECEPTOR 2 [J].
Bock, Ashley ;
Tucker, Nicole ;
Kelher, Marguerite R. ;
Khan, Samina Y. ;
Gonzalez, Eduardo ;
Wohlauer, Max ;
Hansen, Kirk ;
Dzieciatkowska, Monika ;
Sauaia, Angels ;
Banerjee, Anirban ;
Moore, Ernest E. ;
Silliman, Christopher C. .
SHOCK, 2015, 44 (02) :137-142
[6]
Developing a spinal cord injury research strategy using a structured process of evidence review and stakeholder dialogue. Part II: Background to a research strategy [J].
Bragge, P. ;
Piccenna, L. ;
Middleton, J. ;
Williams, S. ;
Creasey, G. ;
Dunlop, S. ;
Brown, D. ;
Gruen, R. .
SPINAL CORD, 2015, 53 (10) :721-728
[7]
Interferon-β induces transient systemic IP-10/CXCL10 chemokine release in patients with multiple sclerosis [J].
Buttmann, M ;
Merzyn, C ;
Rieckmann, P .
JOURNAL OF NEUROIMMUNOLOGY, 2004, 156 (1-2) :195-203
[8]
Elevation of neuron-specific enolase and S-100β protein level in experimental acute spinal cord injury [J].
Cao, Fei ;
Yang, Xiao-feng ;
Liu, Wei-guo ;
Hu, Wei-wei ;
Li, Gu ;
Zheng, Xiu-jue ;
Shen, Fang ;
Zhao, Xue-qun ;
Lv, Shi-ting .
JOURNAL OF CLINICAL NEUROSCIENCE, 2008, 15 (05) :541-544
[9]
Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury [J].
Chakrabarti, Mrinmay ;
Das, Arabinda ;
Samantaray, Supriti ;
Smith, Joshua A. ;
Banik, Naren L. ;
Haque, Azizul ;
Ray, Swapan K. .
REVIEWS IN THE NEUROSCIENCES, 2016, 27 (03) :271-281
[10]
Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration [J].
Chakrabarti, Mrinrnay ;
Haque, Azizul ;
Banik, Naren L. ;
Nagarkatti, Prakash ;
Nagarkatti, Mitzi ;
Ray, Swapan K. .
BRAIN RESEARCH BULLETIN, 2014, 109 :22-31